Growth Metrics

Anavex Life Sciences (AVXL) Treasury Shares (2013 - 2024)

Anavex Life Sciences recorded quarterly Treasury Shares of $2.4 million in Q3 2024, down 25.19% quarter-over-quarter from $3.3 million in Q3 2023, and down 25.19% year-over-year from $3.3 million in Q4 2023.

Anavex Life Sciences' Treasury Shares history runs 12 years deep, the most recent figure standing at $2.4 million for Q3 2024.

  • In Q3 2024, Treasury Shares fell 25.19% year-over-year to $2.4 million; the TTM figure through Sep 2024 stood at $2.4 million (down 25.19% YoY), while the FY2024 annual figure was $2.4 million, down 25.19% from the prior year.
  • Treasury Shares came in at $2.4 million for Q3 2024 at Anavex Life Sciences, down from $3.3 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $7.6 million in Q3 2020 to a low of $160000.0 in Q4 2021.
  • A 5-year average of $1.6 million and a median of $500000.0 in 2020 frame the typical range for Treasury Shares.
  • Across the five-year window, Treasury Shares soared 2061.31% in 2020 and slumped 96.01% in 2022, its largest moves.
  • Anavex Life Sciences' Treasury Shares stood at $500000.0 in 2020, then slumped by 68.0% to $160000.0 in 2021, then changed by 0.0% to $160000.0 in 2022, then surged by 1946.88% to $3.3 million in 2023, then fell by 25.19% to $2.4 million in 2024.
  • According to Business Quant data, Treasury Shares over the past three periods registered $2.4 million, $3.3 million, and $1.0 million for Q3 2024, Q3 2023, and Q2 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 265,401.92
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 700,000.00
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 34.70 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Anavex Life Sciences 266.20 Mn 134.45 Mn - -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2024 2.45 Mn
Sep 30, 2024 2.45 Mn
Sep 30, 2023 3.28 Mn
Sep 30, 2023 3.28 Mn
Jun 30, 2023 1.05 Mn
Jun 30, 2023 1.05 Mn
Mar 31, 2023 2.08 Mn
Mar 31, 2023 2.08 Mn
Sep 30, 2022 160,000.00
Sep 30, 2022 160,000.00
Jun 30, 2022 160,000.00
Jun 30, 2022 160,000.00
Mar 31, 2022 160,000.00
Mar 31, 2022 160,000.00
Dec 31, 2021 160,000.00
Dec 31, 2021 160,000.00
Sep 30, 2021 4.01 Mn
Sep 30, 2021 4.01 Mn
Jun 30, 2021 210,000.00
Jun 30, 2021 210,000.00
Mar 31, 2021 500,000.00
Mar 31, 2021 500,000.00
Dec 31, 2020 500,000.00
Dec 31, 2020 500,000.00
Sep 30, 2020 7.56 Mn
Sep 30, 2020 7.56 Mn
Jun 30, 2020 500,000.00
Jun 30, 2020 500,000.00
Mar 31, 2020 500,000.00
Mar 31, 2020 500,000.00
Dec 31, 2019 500,000.00
Dec 31, 2019 500,000.00
Sep 30, 2019 350,000.00
Sep 30, 2019 350,000.00
Jun 30, 2019 357,500.00
Jun 30, 2019 357,500.00
Mar 31, 2019 370,000.00
Mar 31, 2019 370,000.00
Dec 31, 2018 678,379.00
Dec 31, 2018 678,379.00
Sep 30, 2018 678,379.00
Sep 30, 2018 678,379.00
Jun 30, 2018 1.59 Mn
Jun 30, 2018 1.59 Mn
Mar 31, 2018 1.61 Mn
Mar 31, 2018 1.61 Mn
Dec 31, 2017 1.61 Mn
Dec 31, 2017 1.61 Mn
Sep 30, 2017 1.61 Mn
Sep 30, 2017 1.61 Mn
Jun 30, 2017 1.61 Mn
Jun 30, 2017 1.61 Mn
Mar 31, 2017 1.61 Mn
Mar 31, 2017 1.61 Mn
Sep 30, 2016 1.81 Mn
Sep 30, 2016 1.81 Mn
Jun 30, 2016 1.81 Mn
Jun 30, 2016 1.81 Mn
Mar 31, 2016 1.83 Mn
Mar 31, 2016 1.83 Mn
Dec 31, 2015 1.83 Mn
Dec 31, 2015 1.83 Mn
Sep 30, 2015 4.27 Mn
Sep 30, 2015 4.27 Mn
Sep 30, 2014 18.73 Mn
Sep 30, 2014 18.73 Mn
Sep 30, 2013 2.29 Mn
Sep 30, 2013 2.29 Mn